22 Apr 2020
Mark Maietta has a career spanning across 20 years including leadership roles in organisations such as Pfizer, CRF and Clariness. He is currently the President and Chief Commercial Officer at YPrime, a major player in eCOA, IRT, clinical data science and analytics. In this podcast, Mark discusses his view on the possible short, medium and long term implications of Covid on the pharmaceutical sector.
Listen to the Podcast below:
Services
Services
9 Greyfriars Road,
Reading,
Berkshire,
RG1 1NU
t: +44 (0)118 935 9444
e: info@spencergroup.com
Website by Supreme